Comparison of the Cosmetic Effects of Bakuchiol and Retinol
Launched by UNIVERSITY OF CALIFORNIA, DAVIS · Apr 7, 2017
Trial Information
Current as of October 02, 2025
Completed
Keywords
ClinConnect Summary
Bakuchiol is a phytochemical that has demonstrated cutaneous antiageing effects when applied topically. Early studies have suggested that bakuchiol is a functional analogue of topical retinoids, as both compounds have been shown to induce similar gene expression in the skin and lead to improvement of cutaneous photodamage. No in vivo studies have compared the two compounds for efficacy and side-effects.
The aim of this study is to compare the cosmetic effects of Bakuchiol to Retinol over a 12-week period.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Individuals aged 30-55
- Exclusion Criteria:
- • Adults unable to consent
- • Individuals who are not yet adults (infants, children, teenagers)
- • Pregnant or breast feeding women
- • Prisoners
- • Those with acne, eczema, seborrheic dermatitis, rosacea or polycystic ovarian syndrome
- • Those who have used isotretinoin in the last 6 months
- • Those who have used products containing salicylic acid, beta hydroxyl acids or vitamins A, C, or E in the last 14 days
- • Those who have used topical antibiotics or topical retinoids in the last 30 days
- • Those who are currently smoking or have smoked within the past 3 years.
- • Those who have had a recent surgical or cosmetic procedure in the last 3 months that can affect facial wrinkles or facial hyperpigmentation, such as botulinum toxin injections, chemical peels, laser based therapies to the face, or face lift surgeries
About University Of California, Davis
The University of California, Davis (UC Davis) is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials and studies. With a strong focus on interdisciplinary collaboration, UC Davis leverages its extensive expertise in medical research, education, and patient care to drive breakthroughs in various fields, including medicine, public health, and agriculture. The university's clinical trial programs emphasize rigorous scientific methodology and ethical standards, aiming to translate research findings into impactful treatments and improved patient outcomes. Through its state-of-the-art facilities and a dedicated team of researchers and healthcare professionals, UC Davis is at the forefront of transforming healthcare practices and addressing critical health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sacramento, California, United States
Patients applied
Trial Officials
Raja Sivamani, MD
Principal Investigator
UC Davis
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials